Rexulti and Ezetimibe drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rexulti and Ezetimibe. Common interactions include osteoporosis among females and anaemia among males.

The phase IV clinical study analyzes what interactions people who take Rexulti and Ezetimibe have. It is created by eHealthMe based on reports of 11 people who take Rexulti and Ezetimibe from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On May, 26, 2023

11 people who take Rexulti and Ezetimibe together, and have interactions are studied.

What is Rexulti?

Rexulti has active ingredients of brexpiprazole. It is often used in major depression. eHealthMe is studying from 10,659 Rexulti users for its effectiveness, alternative drugs and more.

What is Ezetimibe?

Ezetimibe has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 20,719 Ezetimibe users for its effectiveness, alternative drugs and more.

Number of Rexulti and Ezetimibe reports submitted per year:

Common Rexulti and Ezetimibe drug interactions by gender *:

female:

Osteoporosis
Psoriatic arthropathy
Sleep apnoea syndrome
Ulcer haemorrhage
Anxiety
Dyspepsia
Abscess
Aortic aneurysm
Bruxism
Haematuria

male:

Anaemia
Anhedonia
Fatigue
Gait disturbance
General physical condition
Glycosuria
Hyperphosphataemia
Malaise
Musculoskeletal pain
Nephrolithiasis

Common Rexulti and Ezetimibe drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Abscess
Anaemia
Emotional distress
Fanconi syndrome acquired
Fatigue
Gait disturbance
General physical condition
Glycosuria
Hyperphosphataemia
Malaise

60+:

n/a

Common conditions people have *:

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 54.55%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 27.27%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 9.09%
Pain: 1 person, 9.09%
Nasal Polyps (masses that develop in the lining of the nose): 1 person, 9.09%
Hiv Infection: 1 person, 9.09%
Ear Pain: 1 person, 9.09%
Depression: 1 person, 9.09%
Bipolar Ii Disorder (characterized by at least one episode of hypomania and at least one episode of major depression): 1 person, 9.09%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Rexulti and Ezetimibe?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.